Browse classification

Loading Please Wait
K:SECTIONS K TO T: INDEXING SCHEMES.
 K61:
  K61L: INDEXING SCHEME RELATING TO METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
   K61L2/00: Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
   K61L2/00P: for pharmaceuticals, biologicals or living parts
   K61L2/00P2: . . using physical methods
   K61L2/00P2A: . . . Filtration
   K61L2/00P2E: . . . Heat
   K61L2/00P2F: . . . Gamma radiatio
   K61L2/00P2R: . . . Radiation
   K61L2/00P2R10: . . . . Infrared radiation
   K61L2/00P2R12: . . . . Microwaves
   K61L2/00P2R14: . . . . Particle radiation, e.g. electron-beam, alpha or beta radiation
   K61L2/00P2R16: . . . . using a photocatalyst or photosensitiser
   K61L2/00P2R2: . . . . Gamma radiation
   K61L2/00P2R4: . . . . X-rays
   K61L2/00P2R6: . . . . Ultraviolet radiation
   K61L2/00P2R8: . . . . Visible light
   K61L2/00P4: . . using chemical substances
   K61L2/00P4A: . . . Liquid substances
   K61L2/00P4E: . . . Gaseous substances
   K61L2/02: using physical phenomena
   K61L2/025: . . Ultrasonics
   K61L2/02F: . . Filtration
   K61L2/03: . . Electric current
   K61L2/03E: . . . Electrolysis
   K61L2/04: . . Heat
   K61L2/50: Apparatus features
   K61L2/06: . . . Hot gas
   K61L2/60: Targets to be treated
   K61L2/07: . . . . Steam
   K61L2/08: . . Radiation
   K61L2/08B: . . . Gamma radiation
   K61L2/08D: . . . X-rays
   K61L2/08F: . . . Visible light
   K61L2/08H: . . . Infrared radiation
   K61L2/08J: . . . Particle radiation, e.g. electron-beam, alpha or beta radiation
   K61L2/08L: . . . using a photocatalyst or photosensitiser
   K61L2/10: . . . Ultra-violet radiation
   K61L2/12: . . . Microwaves
   K61L2/14: . . Plasma, i.e. ionised gases
   K61L2/16: using chemical substances
   K61L2/18: . . Liquid substances or solutions comprising solids or dissolved gases
   K61L2/18L: . . . Ozone dissolved in a liquid
   K61L2/18P: . . . Peroxide solutions
   K61L2/20: . . Gaseous substances, e.g. vapours
   K61L2/20C: . . . Ozone
   K61L2/20D: . . . Formaldehyde
   K61L2/20E: . . . Ethylene oxide
   K61L2/20H: . . . Hydrogen peroxide
   K61L2/22: . . Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
   K61L2/23: . . Solid substances, e.g. granules, powders, blocks, tablets
   K61L2/232: . . . layered or coated
   K61L2/235: . . . cellular, porous or foamed
   K61L2/238: . . . Metals or alloys, e.g. oligodynamic metals
   K61L2/24: Apparatus using programmed or automatic operation
   K61L2/26: Accessories or devices or components used for biocidal treatment
   K61L2/28: . . Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
   K61L2/510: . . Generating biocidal substance
   K61L2/520: . . Isolating biocidal substance from the environment
   K61L2/521: . . . Sealing means (e.g. doors, covers, valves, sluices)
   K61L2/522: . . . Chambers for sterilisation
   K61L2/523: . . . Connecting means
   K61L2/530: . . Biocide decomposition means (e.g. catalyst, sorbent)
   K61L2/540: . . Controlling sterilisation process (e.g. sensors, controllers, programs), data processing, presentation and storage means
   K61L2/550: . . Biocide distributing means
   K61L2/560: . . Mobile applications (e.g. portable devices, trailers, devices mounted on vehicles)
   K61L2/570: . . Combined with washing/cleaning means
   K61L2/580: . . Aseptic storing means
   K61L2/581: . . . Flexible packaging means (e.g. permeable membranes, paper)
   K61L2/582: . . . Storage containers, rigid
   K61L2/610: . . Pharmaceuticals
   K61L2/620: . . Blood and its products
   K61L2/630: . . Containers
   K61L2/640: . . Medical instruments
   K61L2/650: . . Rooms in buildings, passenger compartments
   K61L2/660: . . Textiles (e.g. towels, beds, cloths; Physical and chemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials - D06M)
   K61L9/00: Disinfection, sterilisation or deodorisation of air
   K61L9/01: Deodorant compositions
   K61L9/012: . . characterised by being in a special form, e.g. gels, emulsions
   K61L9/013: . . containing animal or plant extracts, or vegetable material
   K61L9/014: . . containing sorbent material, e.g. activated carbon
   K61L9/015: using gaseous or vaporous substances, e.g. ozone
   K61L9/02: . . using substances evaporated in the air by heating or combustion
   K61L9/03: . . . Apparatus therefor
   K61L9/03F: . . . . comprising a fan
   K61L9/03M: . . . . emanating multiple odours
   K61L9/03W: . . . . comprising a wick
   K61L9/04: . . using substances evaporated in the air without heating
   K61L9/04B: . . . with the help of a macromolecular compound as a carrier or diluent
   K61L9/04C: . . . with the help of an organic compound other than a macromolecular compound
   K61L9/04D: . . . with the help of a non-organic compound
   K61L9/04G: . . . air treating gels
   K61L9/05: . . . specially adapted to be released by contact with a liquid, e.g. for toilets
   K61L9/50: Apparatus features
   K61L9/60: Method-related aspects
   K61L9/12: . . . Apparatus, e.g. holders, therefor
   K61L9/12F: . . . . comprising a fan
   K61L9/12M: . . . . emanating multiple odours
   K61L9/12W: . . . . comprising a wick
   K61L9/14: using sprayed or atomised substances including air-liquid contact processes
   K61L9/14L: . . air-liquid contact processes, e.g. scrubbing
   K61L9/16: using physical phenomena
   K61L9/18: . . Radiation
   K61L9/20: . . . Ultra-violet radiation
   K61L9/20P: . . . . using a photocatalyst or photosensitiser
   K61L9/22: . . Ionisation
   K61L9/510: . . Controlling air treatment
   K61L9/511: . . . Sensor means (e.g. motion, brightness, scent, contaminant sensors)
   K61L9/520: . . Lighting means (electric lighting - H05B)
   K61L9/530: . . Dispensing or storing means for active compound (containers for dispensing - B65D83
   K61L9/531: . . . Semipermeable membrane
   K61L9/532: . . . Piezo or ultrasonic element for dispensing (Apparatus for spraying or atomising liquids - B05B17
   K61L9/533: . . . Replaceable cartridge, refills
   K61L9/534: . . . Distributing means (e.g. vaporisers, baffles valves)
   K61L9/535: . . . Specific vaporisers for active component
   K61L9/540: . . Filtering means (filters in the sense of particle separators in general - B01D46)
   K61L9/550: . . Supporting means (e.g. stands, hooks, holes for hanging)
   K61L9/560: . . Connected to a HVAC unit
   K61L9/610: . . Chemical compounds for treating air
   K61L9/611: . . . Hydrogen peroxide (liquid and vaporous)
   K61L9/612: . . . Ozone (e.g. generated by UV radiation or electrical discharge)
   K61L9/613: . . . Electrochemically treated water (e.g. electrolysis water, treated by electrical discharge)
   K61L9/620: . . Treatment by absorption or chemisorption, e.g. in scrubber, wet cleaner
   K61L11/00: Methods specially adapted for refuse
   K61L12/00: Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
   K61L12/02: using physical phenomena, e.g. electricity, ultrasonics or ultrafiltration
   K61L12/02E: . . Electrolysis
   K61L12/02F: . . Ultrasounds
   K61L12/04: . . Heat
   K61L12/06: . . Radiation, e.g. ultraviolet or microwaves
   K61L12/06B: . . . Ultraviolet radiation
   K61L12/06D: . . . Microwaves
   K61L12/08: using chemical substances
   K61L12/08B: . . in combination with specific enzymes
   K61L12/08D: . . in a gaseous state
   K61L12/08F: . . Container, accessories or devices therefor
   K61L12/08H: . . Heavy metals
   K61L12/10: . . Halogens or compounds thereof
   K61L12/10B: . . . Chlorine dioxide (ClO2)
   K61L12/10D: . . . Iodine, iodides or iodophores
   K61L12/10F: . . . Hypohalites; Active halogens
   K61L12/12: . . Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
   K61L12/12B: . . . Ozone
   K61L12/12D: . . . Hydrogen peroxide; Peroxy compounds
   K61L12/12D2: . . . . neutralised with catalase or peroxidase
   K61L12/12D4: . . . . neutralised with catalysts
   K61L12/14: . . Organic compounds not covered by groups A61L12/10 or A61L12/12
   K61L12/14B: . . . Biguanides, e.g. chlorhexidine
   K61L12/14B2: . . . . Polymeric biguanides
   K61L12/14D: . . . Quaternary ammonium compounds
   K61L12/14D2: . . . . Polymeric quaternary ammonium compounds
   K61L12/14F: . . . Aldehydes
   K61L12/14H: . . . Alcohols or derivatives thereof
   K61L12/14K: . . . Mercury containing compounds, e.g. thimerosal
   K61L15/00: Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
   K61L15/07: Stiffening bandages
   K61L15/08: . . containing inorganic materials, e.g. plaster of Paris
   K61L15/10: . . containing organic materials
   K61L15/12: . . containing macromolecular materials
   K61L15/12M: . . . Mixtures of macromolecular compounds
   K61L15/14: . . Use of materials characterised by their function or physical properties
   K61L15/16: Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
   K61L15/18: . . containing inorganic materials
   K61L15/20: . . containing organic materials
   K61L15/22: . . containing macromolecular materials
   K61L15/22M: . . . Mixtures of macromolecular compounds
   K61L15/24: . . . Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence
   K61L15/26: . . . Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence
   K61L15/28: . . . Polysaccharides or their derivatives A61L15/22M takes precedence
   K61L15/30: . . . Rubbers or their derivatives A61L15/22M takes precedence
   K61L15/32: . . . Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin A61L15/22M takes precedence
   K61L15/32A: . . . . Collagen
   K61L15/34: . . . Oils, fats, waxes or natural resins A61L15/22M takes precedence
   K61L15/36: . . containing micro-organisms
   K61L15/38: . . containing enzymes
   K61L15/40: . . containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
   K61L15/42: . . Use of materials characterised by their function or physical properties
   K61L15/42E: . . . Porous materials, e.g. foams or sponges
   K61L15/44: . . . Medicaments
   K61L15/46: . . . Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
   K61L15/48: . . . Surfactants
   K61L15/50: . . . Lubricants; Anti-adhesive agents
   K61L15/52: . . . Water-repellants
   K61L15/54: . . . Radio-opaque materials
   K61L15/56: . . . Wetness-indicators or colourants
   K61L15/58: . . . Adhesives
   K61L15/58M: . . . . Mixtures of macromolecular compounds
   K61L15/60: . . . Liquid-swellable gel-forming materials, e.g. super-absorbents
   K61L15/62: . . . Compostable, hydrosoluble or hydrodegradable materials
   K61L15/64: . . . specially adapted to be resorbable inside the body
   K61L17/00: Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters bone cements or surgical adhesives for soft body tissues A61L24/00; shape or structure of prostheses A61F2/00; shape or structure of catheters A61M5/00
   K61L17/00C: containing a biologically active substance, e.g. a medicament or a biocide
   K61L17/04: Non-resorbable materials
   K61L17/06: At least partially resorbable materials
   K61L17/08: . . of animal origin, e.g. catgut, collagen
   K61L17/10: . . containing macromolecular materials
   K61L17/10B: . . . Polyesters not covered by A61L17/12
   K61L17/12: . . . Homopolymers or copolymers of glycolic acid or lactic acid
   K61L17/14: Post-treatment to improve physical properties
   K61L17/14C: . . Coating
   K61L24/00: Surgical adhesives or cements; Adhesives for colostomy devices
   K61L24/00F: Ingredients of undetermined constitution or reaction products thereof
   K61L24/00H: Use of materials characterised by their function or physical properties
   K61L24/00H2: . . Medicaments; Biocides
   K61L24/00H4: . . Plasticisers
   K61L24/00H6: . . Sprayable compositions
   K61L24/00H7: . . Hydrogels or hydrocolloids
   K61L24/00H8: . . Porous materials, e.g. foams or sponges
   K61L24/00H9: . . Materials resorbable by the body
   K61L24/00R: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   K61L24/00R2: . . with an inorganic matrix
   K61L24/00R2A: . . . Carbon
   K61L24/00R2E: . . . Phosphorus containing materials, e.g. apatite
   K61L24/00R2K: . . . Inorganic materials not covered by groups A61L24/00R2A or A61L24/00R2E
   K61L24/00R4: . . with a macromolecular matrix
   K61L24/00R4A: . . . containing fillers of carbon
   K61L24/00R4E: . . . containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
   K61L24/00R4K: . . . containing inorganic fillers not covered by groups A61L24/00R4A or A61L24/00R4E
   K61L24/00R4R: . . . containing macromolecular fillers
   K61L24/02: containing inorganic materials
   K61L24/04: containing macromolecular materials
   K61L24/04M: . . Mixtures of macromolecular materials
   K61L24/04R: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M takes precedence
   K61L24/06: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M, A61L24/04Rtake precedence
   K61L24/08: . . Polysaccharides A61L24/04M takes precedence
   K61L24/10: . . Polypeptides; Proteins A61L24/04M takes precedence
   K61L24/10A: . . . Collagen
   K61L24/10E: . . . Gelatin
   K61L24/10F: . . . Fibrin; Fibrinogen
   K61L24/10R: . . . Specific proteins or polypeptides not covered by groups A61L24/10A to A61L24/10F
   K61L24/12: . . Ionomer cements, e.g. glass-ionomer cements A61L24/04M takes precedence
   K61L26/00: Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
   K61L26/00A: containing inorganic materials
   K61L26/00B: containing macromolecular materials
   K61L26/00B2: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   K61L26/00B4: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   K61L26/00B5: . . Polysaccharides
   K61L26/00B6: . . Polypeptides; Proteins; Degradation products thereof
   K61L26/00B6A: . . . Collagen
   K61L26/00B6E: . . . Gelatin
   K61L26/00B6F: . . . Fibrin; Fibrinogen
   K61L26/00B6R: . . . Specific proteins or polypeptides not covered by groups A61L26/00B6A to A61L26/00B6F
   K61L26/00B8: . . Mixtures of macromolecular compounds
   K61L26/00F: Ingredients of undeterminded constitution or reaction products thereof
   K61L26/00H: Use of materials characterised by their function or physical properties
   K61L26/00H2: . . Medicaments; Biocides
   K61L26/00H4: . . Plasticisers
   K61L26/00H6: . . Sprayable compositions
   K61L26/00H7: . . Hydrogels or hydrocolloids
   K61L26/00H8: . . Porous materials, e.g. foams or sponges
   K61L26/00H9: . . Materials resorbable by the body
   K61L26/00R: Composite materials, i.e. containing one material dispersed in amatrix of the same or different material
   K61L27/00: Materials for grafts or prostheses or for coating grafts or prostheses
   K61L27/02: Inorganic materials
   K61L27/02B: . . Other specific inorganic materials not covered by A61L27/04 to A61L27/12
   K61L27/04: . . Metals or alloys
   K61L27/04A: . . . Iron or iron alloys
   K61L27/04F: . . . Cobalt or cobalt alloys
   K61L27/04R: . . . Other specific metals or alloys not covered by A61L27/04A to A61L27/04F or A61L27/06
   K61L27/06: . . . Titanium or titanium alloys
   K61L27/08: . . Carbon; Graphite
   K61L27/10: . . Ceramics or glasses
   K61L27/10A: . . . containing Al2O3
   K61L27/12: . . Phosphorus-containing materials, e.g. apatite
   K61L27/14: Macromolecular materials
   K61L27/16: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   K61L27/16B: . . . Rubbers
   K61L27/18: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   K61L27/20: . . Polysaccharides
   K61L27/22: . . Polypeptides or derivatives thereof, e.g. degradation products
   K61L27/22E: . . . Gelatin
   K61L27/22F: . . . Fibrin; Fibrinogen
   K61L27/22R: . . . Other specific proteins or polypeptides not covered by A61L27/22E, A61L27/22F or A61L27/24
   K61L27/24: . . . Collagen
   K61L27/26: . . Mixtures of macromolecular compounds
   K61L27/28: Materials for coating prostheses
   K61L27/30: . . Inorganic materials
   K61L27/30A: . . . Carbon
   K61L27/30R: . . . Other specific inorganic materials not covered by A61L27/30A to A61L27/32
   K61L27/32: . . . Phosphorus-containing materials, e.g. apatite
   K61L27/34: . . Macromolecular materials
   K61L27/36: containing ingredients of undetermined constitution or reaction products thereof
   K61L27/36B: . . characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
   K61L27/36B10: . . . Vascular tissue, e.g. heart valves
   K61L27/36B12: . . . Intestinal tissue, e.g. small intestinal submucosa
   K61L27/36B14: . . . Extracellular matrix (ECM)
   K61L27/36B2: . . . Bone, e.g. demineralised bone matrix [DBM, bone powder]
   K61L27/36B4: . . . Cartilage, synovial fluid
   K61L27/36B6: . . . Blood, e.g. platelet-rich plasma
   K61L27/36B8: . . . Skin, e.g. dermal papillae
   K61L27/36D: . . characterised by the origin of the biological material other than human or animal , e.g. plant extracts, algae
   K61L27/36F: . . characterised by the site of application in the body
   K61L27/36F10: . . . Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
   K61L27/36F2: . . . Connective tissue
   K61L27/36F2B: . . . . Bones
   K61L27/36F2D: . . . . Cartilage, e.g. meniscus
   K61L27/36F2D2: . . . . . Intervertebral discs
   K61L27/36F2F: . . . . Ligaments, tendons
   K61L27/36F4: . . . Epithelial tissues other than skin
   K61L27/36F6: . . . Muscle tissue, e.g. sphincter
   K61L27/36F8: . . . Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
   K61L27/36H: . . subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
   K61L27/36H2: . . . characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
   K61L27/36H4: . . . characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
   K61L27/36H6: . . . characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
   K61L27/38: . . containing added animal cells
   K61L27/38B: . . . characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
   K61L27/38B10: . . . . Muscle cells, e.g. smooth muscle cells
   K61L27/38B12: . . . . Nerve cells, e.g. dendritic cells, Schwann cells
   K61L27/38B14: . . . . Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
   K61L27/38B2: . . . . Endothelial cells
   K61L27/38B4: . . . . Epithelial cells, e.g. keratinocytes, urothelial cells
   K61L27/38B6: . . . . Cartilage-forming cells, e.g. pre-chondrocytes
   K61L27/38B8: . . . . Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
   K61L27/38D: . . . characterised by the site of application in the body
   K61L27/38D10: . . . . Hollow organs, e.g. bladder, esophagus, urether, uterus
   K61L27/38D2: . . . . Connective tissue
   K61L27/38D2B: . . . . . Bones
   K61L27/38D2D: . . . . . Cartilage, e.g. meniscus
   K61L27/38D2D2: . . . . . . Intervertebral discs
   K61L27/38D2F: . . . . . Ligaments, tendons
   K61L27/38D2H: . . . . . Dental/periodontal tissues
   K61L27/38D4: . . . . Epithelial tissues other than skin
   K61L27/38D6: . . . . Muscle tissue, e.g. sphincter
   K61L27/38D8: . . . . Nerve tissue, brain, spinal cord, nerves, dura mater
   K61L27/38F: . . . comprising two or more cell types
   K61L27/38F2: . . . . as distinct cell layers
   K61L27/38H: . . . using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
   K61L27/40: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   K61L27/42: . . having an inorganic matrix
   K61L27/42A: . . . of carbon
   K61L27/42E: . . . of phosphorus containing material, e.g. apatite
   K61L27/42R: . . . of other specific inorganic materials not covered by A61L27/42A or A61L27/42E
   K61L27/44: . . having a macromolecular matrix
   K61L27/44A: . . . with carbon fillers
   K61L27/44R: . . . with other specific inorganic fillers other than those covered by A61L27/44A or A61L27/46
   K61L27/46: . . . with phosphorus-containing inorganic fillers
   K61L27/48: . . . with macromolecular fillers
   K61L27/50: Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
   K61L27/50B: . . Plasticizers
   K61L27/50D: . . Stabilizers
   K61L27/50E: . . for artificial blood vessels apparatus for applying cells on a blood vessel prosthesis A61F2/06B
   K61L27/52: . . Hydrogels or hydrocolloids
   K61L27/54: . . Biologically active materials, e.g. therapeutic substances
   K61L27/56: . . Porous materials, e.g. foams or sponges
   K61L27/58: . . Materials at least partially resorbable by the body
   K61L27/60: . . Materials for use in artificial skin
   K61L28/00: Materials for colostomy devices
   K61L28/00A: containing inorganic materials
   K61L28/00B: containing macromolecular materials
   K61L28/00B2: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   K61L28/00B4: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   K61L28/00B5: . . Polysaccharides
   K61L28/00B6: . . Polypeptides; Proteins; Degradation products thereof
   K61L28/00B8: . . Mixtures of macromolecular compounds
   K61L28/00F: Ingredients of undeterminded constitution or reaction products thereof
   K61L28/00H: Use of materials characterised by their function or physical properties
   K61L28/00H2: . . Medicaments; Biocides
   K61L28/00H4: . . Plasticisers
   K61L28/00H6: . . Sprayable compositions
   K61L28/00H7: . . Hydrogels or hydrocolloids
   K61L28/00H8: . . Porous materials, e.g. foams or sponges
   K61L28/00H9: . . Materials resorbable by the body
   K61L28/00K: Materials for coating
   K61L28/00K2: . . Inorganic materials
   K61L28/00K4: . . Macromolecular materials
   K61L28/00R: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   K61L28/00R2: . . with an inorganic matrix
   K61L28/00R4: . . with a macromolecular matrix
   K61L28/00R4A: . . . containing fillers of carbon
   K61L28/00R4E: . . . containing fillers of phosphorus-containing inorganic compounds
   K61L28/00R4K: . . . containing inorganic fillers not covered by groups A61L28/00R4A or A61L28/00R4E
   K61L28/00R4R: . . . containing macromolecular fillers
   K61L29/00: Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
   K61L29/00F: Ingredients of undetermined constitution or reaction products thereof
   K61L29/02: Inorganic materials
   K61L29/04: Macromolecular materials
   K61L29/04B: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   K61L29/04B2: . . . Rubbers
   K61L29/04D: . . Polysaccharides
   K61L29/04F: . . Proteins; Polypeptides; Degradation products thereof
   K61L29/04F10: . . . Other specific proteins or polypeptides not covered by A61L29/04F2 to A61L29/04F6
   K61L29/04F2: . . . Collagen
   K61L29/04F4: . . . Gelatin
   K61L29/04F6: . . . Fibrin; Fibrinogen
   K61L29/04M: . . Mixtures of macromolecular compounds
   K61L29/06: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   K61L29/08: Materials for coatings
   K61L29/08B: . . Macromolecular materials
   K61L29/10: . . Inorganic materials
   K61L29/10A: . . . Carbon
   K61L29/10R: . . . Inorganic materials other than carbon
   K61L29/12: Composite materials, i.e. containig one material dispersed in a matrix of the same or different material
   K61L29/12B: . . having an inorganic matrix
   K61L29/12D: . . having a macromolecular matrix
   K61L29/14: Materials characterised by their function or physical properties, e.g. lubricating compositions
   K61L29/14B: . . Plasticizers
   K61L29/14D: . . Stabilizers
   K61L29/14F: . . Hydrogels or hydrocolloids
   K61L29/14H: . . Porous materials, e.g. foams or sponges
   K61L29/14K: . . Materials at least partially resorbable by the body
   K61L29/16: . . Biologically active materials, e.g. therapeutic substances
   K61L29/18: . . Materials at least partially X-ray or laser opaque
   K61L31/00: Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices shape or structure of stent-grafts A61F2/07, of stents A61F2/82, of surgical gloves A61B19/04, of surgical drapes A61B19/08, of occluding devices A61B17/12P
   K61L31/00F: Ingredients of undetermined constitution or reaction products thereof
   K61L31/02: Inorganic materials
   K61L31/02B: . . Metals or alloys
   K61L31/02D: . . Carbon; Graphite
   K61L31/02F: . . Ceramic or ceramic-like structures, e.g. glasses
   K61L31/02R: . . Other inorganic materials not covered by A61L31/02B to A61L31/02F
   K61L31/04: Macromolecular materials
   K61L31/04B: . . Mixtures of macromolecular compounds
   K61L31/04D: . . Polysaccharides
   K61L31/04F: . . Proteins; Polypeptides; Degradation products thereof
   K61L31/04F10: . . . Other specific proteins or polypeptides not covered by A61L31/04F2 to A61L31/04F6
   K61L31/04F2: . . . Collagen
   K61L31/04F4: . . . Gelatin
   K61L31/04F6: . . . Fibrin; Fibrinogen
   K61L31/04H: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence
   K61L31/04H3: . . . Rubbers
   K61L31/06: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence
   K61L31/08: Materials for coatings
   K61L31/08B: . . Inorganic materials
   K61L31/08B2: . . . Carbon; Graphite
   K61L31/08B4: . . . Phosphorus-containing materials, e.g. apatite
   K61L31/08B6: . . . Other specific inorganic materials not covered by A61L31/08B2 or A61L31/08B4
   K61L31/10: . . Macromolecular material
   K61L31/12: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   K61L31/12B: . . having an inorganic matrix
   K61L31/12B2: . . . of carbon
   K61L31/12B4: . . . of phosphorus-containing materials , e.g. apatite
   K61L31/12B6: . . . of other specific inorganic materials not coverd by A61L31/12B2 or A61L31/12B4
   K61L31/12D: . . having a macromolecular matrix
   K61L31/12D10: . . . containing macromolecular fillers
   K61L31/12D2: . . . containing carbon fillers
   K61L31/12D4: . . . containing fillers of phosphorus-containing inorganic materials
   K61L31/12D6: . . . containing other specific inorganic fillers not covered by A61L31/12D2 or A61L31/12D4
   K61L31/14: Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
   K61L31/14B: . . Plasticizers
   K61L31/14D: . . Stabilizers
   K61L31/14F: . . Hydrogels or hydrocolloids
   K61L31/14H: . . Porous materials, e.g. foams or sponges
   K61L31/14K: . . Materials at least partially resorbable by the body
   K61L31/16: . . Biologically active materials, e.g. therapeutic substances A61L31/04F10 takes precedence
   K61L31/18: . . Materials at least partially X-ray or laser opaque
   K61L33/00: Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
   K61L33/00H: Use of materials characterised by their function or physical properties
   K61L33/00H2: . . Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
   K61L33/00H2A: . . . using a surface active agent
   K61L33/00H2E: . . . using a quaternized group or a protonated amine group of the substrate
   K61L33/00H2F: . . . using an intermediate layer of polymer
   K61L33/00H2K: . . . using a polymer with positively charged atoms in the polymeric backbone, e.g. ionenes
   K61L33/00H2T: . . . characterised by the choice of an antithrombatic agent other than heparin heparino´d A61L33/08; polypeptides A61L33/12
   K61L33/00H3: . . Enzymes, e.g. urokinase, streptokinase
   K61L33/00H4: . . Plasticizers
   K61L33/00H5: . . Stabilizers
   K61L33/00H7: . . Hydrogels or hydrocolloids
   K61L33/00H8: . . Porous materials, e.g. foams or sponges
   K61L33/00R: Chemical modification of the substrate
   K61L33/00R2: . . by reacting with an organic compound other than heparin
   K61L33/00R4: . . by grafting of a monomer onto the substrate
   K61L33/00T: Physical treatment, e.g. plasma treatment
   K61L33/02: Use of inorganic materials
   K61L33/02B: . . Metal or alloys
   K61L33/02D: . . [N:Carbon; Graphite]
   K61L33/02R: . . Other specific inorganic materials not covered by A61L33/02B or A61L33/02D
   K61L33/04: Use of organic materials, e.g. acetylsalicyclic acid
   K61L33/06: Use of macromolecular materials
   K61L33/06A: . . Mixtures of macromolecular compounds
   K61L33/06B: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence
   K61L33/06B2: . . . Rubbers
   K61L33/06D: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence
   K61L33/08: . . Polysaccharides
   K61L33/12: . . Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
   K61L33/12A: . . . Collagen
   K61L33/12E: . . . Gelatin
   K61L33/12F: . . . Fibrin
   K61L33/12R: . . . Other specific proteins or polypeptides not covered by A61L33/12A to A61L33/12F
   K61L33/18: Use of ingredients of undetermined constitution or reaction products thereof
   K61L202/00: Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
   K61L202/100: Apparatus features
   K61L202/110: . . Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
   K61L202/120: . . Apparatus for isolating biocidal substances from the environment
   K61L202/121: . . . Sealings, e.g. doors, covers, valves, sluices
   K61L202/122: . . . Chambers for sterilisation
   K61L202/123: . . . Connecting means
   K61L202/130: . . Biocide decomposition means, e.g. catalysts, sorbents
   K61L202/140: . . Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
   K61L202/150: . . Biocide distribution means, e.g. nozzles, pumps, manifolds, fans, baffles, sprayers
   K61L202/160: . . Mobile applications, e.g. portable devices, trailers, devices mounted on vehicles
   K61L202/170: . . Combination with washing or cleaning means
   K61L202/180: . . Aseptic storing means
   K61L202/181: . . . Flexible packaging means, e.g. permeable membranes, paper
   K61L202/182: . . . Rigid packaging means
   K61L202/200: Targets to be treated
   K61L202/210: . . Pharmaceuticals, e.g. medicaments, artificial body parts
   K61L202/220: . . Blood or products thereof
   K61L202/230: . . Containers, e.g. vials, bottles, syringes, mail
   K61L202/240: . . Medical instruments, e.g. endoscopes, catheters, sharps
   K61L202/250: . . Rooms in buildings, passenger compartments
   K61L202/260: . . Textiles, e.g. towels, beds, cloths
   K61L209/00: Aspects relating to disinfection, sterilisation or deodorisation of air
   K61L209/100: Apparatus features
   K61L209/110: . . Apparatus for controlling air treatment
   K61L209/111: . . . Sensor means, e.g. motion, brightness, scent, contaminant sensors
   K61L209/120: . . Lighting means
   K61L209/130: . . Dispensing or storing means for active compounds
   K61L209/131: . . . Semi-permeable membranes
   K61L209/132: . . . Piezo or ultrasonic elements for dispensing
   K61L209/133: . . . Replaceable cartridges, refills
   K61L209/134: . . . Distributing means, e.g. baffles, valves, manifolds, nozzles
   K61L209/135: . . . Vaporisers for active components
   K61L209/140: . . Filtering means
   K61L209/150: . . Supporting means, e.g. stands, hooks, holes for hanging
   K61L209/160: . . Connections to a HVAC unit
   K61L209/200: Method-related aspects
   K61L209/210: . . Use of chemical compounds for treating air or the like
   K61L209/211: . . . Use of hydrogen peroxide, liquid and vaporous
   K61L209/212: . . . Use of ozone, e.g. generated by UV radiation or electrical discharge
   K61L209/213: . . . Use of electrochemically treated water, e.g. electrolysed water or water treated by electrical discharge
   K61L209/220: . . Treatment by sorption, e.g. absorption, adsorption, chemisorption, scrubbing, wet cleaning
   K61L300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
   K61L300/10: containing or releasing inorganic materials
   K61L300/102: . . Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
   K61L300/104: . . . Silver, e.g. silver sulfadiazine
   K61L300/106: . . Halogens or compounds thereof, e.g. iodine, chlorite
   K61L300/108: . . Elemental carbon , e.g. charcoal
   K61L300/110: . . Peroxy compounds, peroxides, e.g. hydrogen peroxide
   K61L300/112: . . Phosphorus-containing compounds, e.g. phosphates, phosphonates
   K61L300/114: . . Nitric oxide, i.e. NO
   K61L300/20: containing or releasing organic materials
   K61L300/202: . . with halogen atoms, e.g. triclosan, povidone-iodine
   K61L300/204: . . with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
   K61L300/206: . . . Biguanides, e.g. chlorohexidine
   K61L300/208: . . . Quaternary ammonium compounds
   K61L300/210: . . Acids [M1108]
   K61L300/212: . . . Peroxy acids, peracids
   K61L300/214: . . . Amino acids
   K61L300/216: . . with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
   K61L300/220: . . Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
   K61L300/222: . . . Steroids, e.g. corticosteroids
   K61L300/224: . . containing metals, e.g. porphyrins, vitamin B12
   K61L300/230: . . Carbohydrates
   K61L300/232: . . . Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
   K61L300/234: . . . Polysaccharides, lipopolysaccharides
   K61L300/236: . . . Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
   K61L300/250: . . Peptides having up to 20 amino acids in a defined sequence
   K61L300/252: . . Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
   K61L300/254: . . . Enzymes, proenzymes
   K61L300/256: . . . Antibodies, e.g. immunoglobulins, vaccines
   K61L300/258: . . Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
   K61L300/300: . . Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
   K61L300/40: characterised by a specific therapeutic activity or mode of action
   K61L300/402: . . Anaestetics , analgesics, e.g. lidocaine
   K61L300/404: . . Biocides, antimicrobial agents, antiseptic agents
   K61L300/406: . . . Antibiotics
   K61L300/408: . . . Virucides, spermicides
   K61L300/410: . . Anti-inflammatory agents, e.g. NSAIDs
   K61L300/412: . . Tissue-regenerating or healing or proliferative agents
   K61L300/414: . . . Growth factors
   K61L300/416: . . Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
   K61L300/418: . . Agents promoting blood coagulation, blood-clotting agents, embolising agents
   K61L300/420: . . Anti-thrombotic agents, anticoagulants, anti-platelet agents
   K61L300/422: . . Anti-atherosclerotic agents
   K61L300/424: . . Anti-adhesion agents
   K61L300/426: . . Immunomodulating agents, i.e. cytokines, interleukins, interferons
   K61L300/428: . . Vitamins, e.g. tocopherol, riboflavin
   K61L300/430: . . Hormones, e.g. dexamethasone
   K61L300/432: . . Inhibitors, antagonists
   K61L300/434: . . . of enzymes
   K61L300/436: . . . of receptors
   K61L300/438: . . Antigens
   K61L300/440: . . Radioisotopes, radionuclides
   K61L300/442: . . Colorants, dyes
   K61L300/450: . . Mixtures of two or more drugs, e.g. synergistic mixtures
   K61L300/452: . . Lubricants
   K61L300/60: characterised by a special physical form
   K61L300/602: . . Type of release, e.g. controlled, sustained, slow
   K61L300/604: . . . Biodegradation
   K61L300/606: . . Coatings
   K61L300/608: . . . having two or more layers
   K61L300/610: . . . . containing two or more active agents in different layers
   K61L300/620: . . Encapsulated active agents, e.g. emulsified droplets
   K61L300/622: . . . Microcapsules
   K61L300/624: . . . Nanocapsules
   K61L300/626: . . . Liposomes, micelles, vesicles
   K61L300/630: . . Crystals
   K61L300/640: . . Animal cells
   K61L300/80: characterised by a special chemical form
   K61L300/802: . . Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
   K61L400/00: Materials characterised by their function or physical properties
   K61L400/02: Treatment of implants to prevent calcification or mineralisation in vivo
   K61L400/04: Materials for stopping bleeding
   K61L400/06: Flowable or injectable implant compositions
   K61L400/08: Methods for forming porous structures using a negative form which is filled and then removed by pyrolysis or dissolution
   K61L400/10: Materials for lubricating medical devices
   K61L400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
   K61L400/14: Adhesives for ostomy devices
   K61L400/16: Materials with shape-memory or superelastic properties
   K61L400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
   K61L420/00: Materials or methods for coatings medical devices
   K61L420/02: Methods for coating medical devices
   K61L420/04: Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
   K61L420/06: Coatings containing a mixture of two or more compounds
   K61L420/08: Coatings comprising two or more layers
   K61L430/00: Materials or treatment for tissue regeneration
   K61L430/02: for reconstruction of bones; weight-bearing implants
   K61L430/04: for mammary reconstruction
   K61L430/06: for cartilage reconstruction, e.g. meniscus
   K61L430/10: for reconstruction of tendons or ligaments
   K61L430/12: for dental implants or prostheses
   K61L430/14: for ear reconstruction or ear implants, e.g. implantable hearing aids
   K61L430/16: for reconstruction of eye parts, e.g. intraocular lens, cornea
   K61L430/18: for hair reconstruction
   K61L430/20: for reconstruction of the heart, e.g. heart valves
   K61L430/22: for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
   K61L430/24: for joint reconstruction
   K61L430/26: for kidney reconstruction
   K61L430/28: for liver reconstruction
   K61L430/30: for muscle reconstruction
   K61L430/32: for nerve reconstruction
   K61L430/34: for soft tissue reconstruction
   K61L430/36: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
   K61L430/38: for reconstruction of the spine, vertebrae or intervertebral discs
   K61L430/40: Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking